Scott Aaronson, MD

Dr Scott Aaronson is a thought leader in the areas of biological psychiatry, diagnosis, and the integration of somatic and psychological therapies. He is an adjunct professor of psychiatry at the University of Maryland School of Medicine, distinguished life fellow of the American Psychiatric Association, and is a fellow of the American College of Psychiatrists. Dr Aaronson also serves on the boards of the American Society of Clinical Psychopharmacology and the Clinical TMS Society. In addition to his work at The Retreat by Sheppard Pratt, Dr Aaronson is the director of clinical research programs at Sheppard Pratt, where he is the principal investigator for multiple studies on the development of therapies for mood and anxiety disorders.